Riskpilot← Back to searchSign inGet full accessSynartro Ventures AB
ABActiveOrg 5593870123Economic activity was not specified by tax authority · NACE 0000Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-38% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
SEK -1K
-106% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -29K | -38% |
| Net profit | SEK -1K | -106% |
| Total assets | SEK 52K | +18% |
| Equity | SEK 30K | -3% |
| Employees | 0 | — |
Legal name
Synartro Ventures AB
Org number
5593870123
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
30 juni 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall utveckla och kommersialisera läkemedel och bedriva därmed förenlig verksamhet.
Address
Email
info@synartro.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | −0 | — | — |
| EBITDA | −12 | −12 | −21 | −29 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −12 | 12 | −21 | −29 |
| Net financials | — | 0 | — | — |
| Profit before tax | −12 | −12 | 20 | −1 |
| Tax | −0 | −0 | −2 | −0 |
| Net profit | −12 | −12 | 18 | −1 |
| Item | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 44 | 52 |
| Equity | 13 | 13 | 31 | 30 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 12 | 12 | 14 | 22 |
| Total debt | 12 | 12 | 14 | 22 |
EBITDA margin
-2900000.0%
This company
15.8%
Market median
-18354530% vs market
20222024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20222024
Return on equity
-3.3%
This company
18.4%
Market median
-118% vs market
20222024
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20222024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-06-30 – 2022-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-06-01 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Auditor Substitute | Auditor Substitute | 2022 | — | — |
PG Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Synartro AB | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Synartro AB
Synartro Ventures AB Board members of Synartro Ventures AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Maria Francois | Auditor Substitute | 0 companies |
| Per Gustaf Hammar | Audit | 0 companies |
| M H Charlotte Wiberg Larsson | Chairman | 0 companies |
| Bo Torsten Nilsson | Board of Directors | 0 companies |
| Antonio Bermejo Gomez | Board of Directors | 0 companies |
| Per Fredrik Lehmann | Deputy Board Member | 0 companies |
| Peter Jonas Michael Carlborg | Deputy Board Member | 0 companies |
| Magnus Oliver Hurst | Chairman | 0 companies |
| Bo Torsten Patrik Nilsson | Deputy Board Member | 0 companies |